'Bullish Options Flow' in Teva Pharma (TEVA) Continues -Susquehanna
Tweet
Share
E-mail
Get Alerts TEVA Hot Sheet
Price: $36.55 -0.57%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.1%
Revenue Growth %: -5.4%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.1%
Revenue Growth %: -5.4%
Join SI Premium – FREE
Susquehanna options strategist Alison Edwards notes continued bullish options flow in Teva Pharma (NYSE: TEVA), as investors sold 5k Dec 14 Calls at $1.83 closing to buy 7k Dec 15 Calls $for 1.10, opening. Trading makes investor long ~30k Dec 156 calls. Also today, investors bought 13k Jan 17.5 Calls for ~$0.57, adding to a recent wave of Jan 15 Call buying.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Apple announces A20 Pro chip based on 2nm technology
- Dunkin' Boss Named Interim CEO of Inspire Brands Ahead of IPO - WSJ
- Teva plans senior notes offering to refinance existing debt
Create E-mail Alert Related Categories
Options, Trader TalkRelated Entities
Susquehanna International Group of CompaniesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
